| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.5M | +1.1% |
| SG&A Expense | $11.8M | +15.1% |
| Operating Income | -$26.3M | -7.0% |
| Pre-tax Income | -$26.0M | -7.6% |
| Income Tax | $0 | — |
| Net Income | -$26.0M | -7.6% |
| EPS (Basic) | -$87.27 | +0.1% |
| EPS (Diluted) | -$87.27 | +0.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.6M | +148.1% |
| Current Assets | $23.1M | +116.5% |
| Total Assets | $27.2M | +74.4% |
| Current Liabilities | $6.0M | -2.5% |
| Total Liabilities | $9.8M | -9.4% |
| Stockholders' Equity | $17.4M | +265.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.6M | -7.6% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $38.5M | +146.9% |